Infanrix Polio

Pertussis Filamentous Haemagglutinin, the active ingredient in Infanrix Polio, is a vaccine presented as an injectable solution for intramuscular use. It provides active immunity against diphtheria, tetanus, pertussis, and poliomyelitis in infants and young children.

GNH USA supplies Infanrix Polio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Infanrix Polio is a combination vaccine that targets bacterial and viral pathogens responsible for diphtheria, tetanus, pertussis, and poliomyelitis. - Diphtheria: induces protective antibodies to prevent diphtheria infection. - Tetanus: stimulates immunity that blocks tetanus toxin effects. - Pertussis: generates antibodies against pertussis antigens to reduce severe coughing illness. - Poliomyelitis: creates immunity that prevents poliovirus replication and paralysis.

Common Side Effects: - Injection site pain: mild soreness at the injection site. - Redness or swelling: localized skin reaction. - Fever: low‑grade temperature rise within 24‑48 hours. - Irritability: temporary fussiness in infants. - Loss of appetite: reduced feeding for a short period. - Headache: mild headache reported by some recipients.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: rare neurologic event following vaccination. - High fever: temperature above 40°C that may need treatment. - Prolonged crying: excessive crying lasting more than three hours. - Guillain‑Barré syndrome: extremely rare autoimmune neuropathy. - Hypotonic‑hyporesponsive episodes: transient loss of muscle tone in infants.

Infanrix Polio should be administered according to national immunisation schedules for infants and children. - Allergy: avoid if the patient has a severe allergic reaction to any vaccine component. - Acute illness: postpone vaccination during moderate or severe febrile illness. - Immunocompromised: consult a healthcare professional before use. - Concurrent vaccines: may be given with other vaccines as per guidelines. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Infanrix Polio may interact with other agents that affect immune response. Major Interactions (Avoid): - Live attenuated vaccines: avoid simultaneous administration with oral polio vaccine. - Immunoglobulins or blood products: may reduce vaccine efficacy. Moderate Interactions (Monitor Closely): - Antipyretics: can mask post‑vaccination fever. - Corticosteroids: may blunt immune response when given in high doses. - Antibiotics: generally no effect, but monitor if high‑dose therapy is ongoing.